Investment catalyzes Tute Genomics’ efforts to enable genome-guided, individualized medicine in everyday healthcare. FOR IMMEDIATE RELEASE PROVO, Utah, June 16, 2015 – Tute Genomics, a leader in cloud-based analytics, interpretation, and reporting for clinical sequencing, today announced the closing of its Series A1 round of venture capital funding. The company raised over $3.9 million from … Continue reading Tute Genomics Closes Additional Series A1 Funding With Strategic Investment From Intermountain Healthcare, Healthbox, and Tencent
Category: Featured
Featured Posts
No Child Left Undiagnosed
“We envision a world where every child and every patient who requires a diagnosis receives one, in time for it to make a difference.” Reid Robison, MD CEO of Tute Genomics LAYING THE FOUNDATION FOR PRECISION MEDICINE “The scientific man does not aim at an immediate result. He does not expect that his advanced ideas will … Continue reading No Child Left Undiagnosed
Exploring Genetic Variation with Google Genomics and Tute
Human genome sequencing is fast becoming standard practice for both clinicians and researchers now that the cost to read all 3 billion letters of a person’s DNA has dropped to just a few thousand dollars. But what does all that information mean for medicine and health? At Tute Genomics we’re answering that question by building … Continue reading Exploring Genetic Variation with Google Genomics and Tute
PRESS RELEASE: Tute Genomics Shares Database of 8.5 Billion Genetic Variants on Google Genomics
March 12, 2015 | Google Genomics wants to play seriously in the genomics space, and the company is busy stocking its sandbox with all the best toys. Google Genomics and Tute Genomics have announced that a Tute database of 8.5 billion annotations of genetic variants is publicly available through Google Genomics. The database will be … Continue reading PRESS RELEASE: Tute Genomics Shares Database of 8.5 Billion Genetic Variants on Google Genomics
Rare Disease Day 2015
Rare Disease Day is a worldwide day of recognition for the individuals that suffer with a recorded 7000 rare diseases. A “rare disease” is defined in the United States as a disease that affect fewer than 200,000 people at any one time, although standards vary by the country. Rare diseases, taken together, are estimated to affect 10% … Continue reading Rare Disease Day 2015
THE GENOME WAR (Round Two)
Venter versus Collins (again) and the Race for Precision Medicine in the Petabyte Era. The Precision Medicine Initiative announced by President Obama in 2015 State of the Union Address has created quite a stir, with the overall tone being one of optimism for the future of personalized medicine. The driving force behind this enormous undertaking … Continue reading THE GENOME WAR (Round Two)
CEO Dr. Reid Robison Speaks at SLAS2015 Conference
Last week, CEO Dr. Reid Robison spoke at the 2015 SLAS (Society for Lab Automation and Screening) conference. Held Feb. 7-11, 2015, the fourth annual SLAS Conference and Exhibition hosted 4,695 participants from 34 countries. Dr. Robison spoke about innovations in genome analysis, an Tute’s role in the future of precision medicine (including a special … Continue reading CEO Dr. Reid Robison Speaks at SLAS2015 Conference
Tute Genomics Honored with “Best Utah Health Startup” Award!
We are excited to announce that Tute Genomics has been named “Best Utah Health Startup” by StartSLC! StartSLC is Utah’s Largest Grassroots Startup Festival, held over three days in January. In addition to hosting the Utah Startup Awards, the conference involves workshops, guest speakers (including CEO Reid Robison), a Hackathon, and a Pitch Competition. We at Tute … Continue reading Tute Genomics Honored with “Best Utah Health Startup” Award!